Tocilizumab for intestinal amyloidosis complicated by multi-centric Castleman's disease - 14/12/15
Doi : 10.1016/j.clinre.2015.05.003
Tadahiko Tamura a, Shinobu Tamura b, ⁎ 
, Hironori Tanaka c, Yuko Ohagi a, Fumitaka Taniguchi d, Hirofumi Yamanishi d, Toshihisa Kohara d, Ritsuko Kimura d, Toshio Kurihara e, Takashi Ozaki f, Yoshio Nakano a, Tokuzo Fujimoto a
, Hironori Tanaka c, Yuko Ohagi a, Fumitaka Taniguchi d, Hirofumi Yamanishi d, Toshihisa Kohara d, Ritsuko Kimura d, Toshio Kurihara e, Takashi Ozaki f, Yoshio Nakano a, Tokuzo Fujimoto a a Department of Internal Medicine, Kinan Hospital, Wakayama, Japan
b Department of Hematology and Oncology, Kinan Hospital, Wakayama, Japan
c Department of Internal Medicine, Shingu Municipal Medical Center, Wakayama, Japan
d Department of Gastroenterology, Kinan Hospital, Wakayama, Japan
e Department of Pharmacy, Kinan Hospital, Wakayama, Japan
f Department of Clinical Laboratory, Kinan Hospital, Wakayama, Japan
⁎Corresponding author. Department of Hematology and Oncology, Kinan Hospital, 46-70, Shinjo, Tanabe City, Wakayama, Japan. Tel.: +81 739 225000.
Le texte complet de cet article est disponible en PDF.
Plan
© 2015
Elsevier Masson SAS. Tous droits réservés.
Vol 39 - N° 6
P. e79-e81 - décembre 2015 Retour au numéro
Article précédent
- Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial
- Simon Pernot, Pascal Artru, François Mithieux, Julien Marsot, Emmanuel Watkin, Olivier Pellerin, Gerard Lledo, Philippe Chalabreysse, Jérome Desramé, Julien Taieb
- Treatment of severe refractory de novo auto-immune hepatitis after liver transplantation with plasmapheresis
- Jérôme Dumortier, Jean-Yves Scoazec, Olivier Guillaud, Olivier Hequet, Valérie Hervieu, Olivier Boillot
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?